Cantor Fitzgerald Reiterates Overweight on Biohaven
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Charles Duncan has reiterated an Overweight rating on Biohaven (NYSE:BHVN).
May 30, 2024 | 3:39 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cantor Fitzgerald analyst Charles Duncan has reiterated an Overweight rating on Biohaven, indicating a positive outlook for the stock.
An Overweight rating from a reputable analyst like Charles Duncan suggests confidence in Biohaven's future performance, likely leading to positive short-term price movement.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100